Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation

Background: Allergic asthma is a long-term disorder of the airways resulting from overexpression of immunoglobulin E (IgE) in response to environmental allergens. Patients with poorly controlled asthma are at high risk of exacerbations requiring additional treatment, including hospitalisations. Seve...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: G Norman, R Faria, F Paton, A Llewellyn, D Fox, S Palmer, I Clifton, J Paton, N Woolacott, C McKenna
Médium: Artigo
Jazyk:Inglês
Vydáno: NIHR Journals Library 2013-11-01
Edice:Health Technology Assessment
Témata:
adults
asthma
children
omalizumab
systematic review
On-line přístup:https://doi.org/10.3310/hta17520
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky